Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Cancer Letters
|
July 4, 2024
MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy
Elena Richiardone, Rim Al Roumi, Fanny Lardinois, et al.
Molecular Cancer Therapeutics
|
October 11, 2013
BRAF V600E is a determinant of sensitivity to proteasome inhibitors
Davide Zecchin, Valentina Boscaro, Enzo Medico, et al.
Cell Death & Disease
|
February 9, 2023
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
Marta Falcinelli, Giulia Dell'Omo, Elena Grassi, et al.
Targeted Oncology
|
April 13, 2010
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) [corrected] oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer
Andrea Sartore-Bianchi, Katia Bencardino, Federica Di Nicolantonio, et al.
Cancer Letters
|
February 3, 2025
Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers
Elena Richiardone, Maria Virginia Giolito, Rim Al Roumi, et al.
Science Translational Medicine
|
February 28, 2020
High-dose vitamin C enhances cancer immunotherapy
Alessandro Magrì, Giovanni Germano, Annalisa Lorenzato, et al.
Science Translational Medicine
|
February 5, 2016
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations
Sabrina Arena, Giulia Siravegna, Benedetta Mussolin, et al.
Frontiers in Oncology
|
February 23, 2023
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient
Erica Torchiaro, Consalvo Petti, Sabrina Arena, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2008
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses
Federica Di Nicolantonio, Sabrina Arena, Margherita Gallicchio, et al.
Cancers
|
March 19, 2020
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer
Annalisa Lorenzato, Alessandro Magrì, Vittoria Matafora, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Cancer Letters
|
July 4, 2024
MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy
Elena Richiardone, Rim Al Roumi, Fanny Lardinois, et al.
Molecular Cancer Therapeutics
|
October 11, 2013
BRAF V600E is a determinant of sensitivity to proteasome inhibitors
Davide Zecchin, Valentina Boscaro, Enzo Medico, et al.
Cell Death & Disease
|
February 9, 2023
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
Marta Falcinelli, Giulia Dell'Omo, Elena Grassi, et al.
Targeted Oncology
|
April 13, 2010
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) [corrected] oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer
Andrea Sartore-Bianchi, Katia Bencardino, Federica Di Nicolantonio, et al.
Cancer Letters
|
February 3, 2025
Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers
Elena Richiardone, Maria Virginia Giolito, Rim Al Roumi, et al.
Science Translational Medicine
|
February 28, 2020
High-dose vitamin C enhances cancer immunotherapy
Alessandro Magrì, Giovanni Germano, Annalisa Lorenzato, et al.
Science Translational Medicine
|
February 5, 2016
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations
Sabrina Arena, Giulia Siravegna, Benedetta Mussolin, et al.
Frontiers in Oncology
|
February 23, 2023
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient
Erica Torchiaro, Consalvo Petti, Sabrina Arena, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2008
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses
Federica Di Nicolantonio, Sabrina Arena, Margherita Gallicchio, et al.
Cancers
|
March 19, 2020
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer
Annalisa Lorenzato, Alessandro Magrì, Vittoria Matafora, et al.
Page
of 6